On March 24, 2025, CRH was removed from the FTSE All-World Index, highlighting a significant adjustment in its market presence. This index change is an important context for the company's flat price move over the last quarter. Despite strong Q4 2024 earnings and a 6% increased dividend declaration, these positive factors were tempered by market nervousness and external trends, including ongoing tariff discussions affecting global stocks and CRH's subsequent adjustments to hedge these shifts. As competing shares rallied, CRH's index drop likely overshadowed its promising financial results in this uninspiring market momentum. You should learn about the 2 weaknesses we've spotted with CRH.NYSE:CRH Earnings Per Share Growth as at Mar 2025 Uncover 14 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. CRH's shareholders have enjoyed a very large total return of 319.41% over the past five years, driven by several key developments. The company's earnings have grown significantly, averaging an annual increase of over 21.3%, with a focus on U.S. expansions bolstering their growth. Investments like those in Texas and Florida have leveraged population and infrastructure demands, underpinning revenue and margin enhancements. Further, the company's robust capital allocation facilitated strategic acquisitions, contributing to operational synergies and EBITDA growth. Additionally, CRH has actively managed its capital structure, completing a buyback of over 2.67 million shares recently. The consistent increases in dividend declarations, such as the most recent rise to US$0.37 per share, have also rewarded shareholders. While CRH matched the U.S. market returns over the past year, it notably surpassed its industry peers, highlighting its competitive edge within the Basic Materials sector. Take a closer look at CRH's potential here in our financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:CRH. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
CRH (NYSE:CRH) Sees 3% Drop After FTSE All-World Index Exit
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...